Source: European Medicines Agency (EU) Revision Year: 2025 Publisher: Novo Nordisk A/S, Novo Alle 1, DK-2880 Bagsvaerd, Denmark
Zegalogue 0.6 mg solution for injection in pre-filled syringe.
| Pharmaceutical Form |
|---|
|
Solution for injection (injection). Clear, colorless solution, pH 6.5 and osmolality of 330-490 mOsm/kg. |
Each pre-filled syringe contains 0.6 mg dasiglucagon (as hydrochloride) in 0.6 mL.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Dasiglucagon is a glucagon receptor agonist analogue, which increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver. Hepatic stores of glycogen are necessary for dasiglucagon to produce an antihypoglycaemic effect. |
| List of Excipients |
|---|
|
Trometamol |
Zegalogue 0.6 mg solution for injection in pre-filled syringe:
Glass (type I) pre-filled syringe with staked stainless steel needle, rigid needle shield/grey needle cover, rubber plunger (bromobutyl) and red plunger rod (polypropylene). Each pre-filled syringe contains 0.6 mL of solution for injection and is individually packaged in a protective case.
Pack sizes of 1 or 2 single-dose pre-filled syringes.
Not all pack sizes or presentations may be marketed.
Novo Nordisk A/S, Novo Alle 1, DK-2880 Bagsvaerd, Denmark
EU/1/24/1829/003
EU/1/24/1829/004
Date of first authorisation: 24 July 2024
| Drug | Countries | |
|---|---|---|
| ZEGALOGUE | Estonia, Lithuania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.